Dry powder inhalers can improve patient outcomes and lower environmental impact

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

Dry Powder Inhalers: A Double Win for COPD and Environment

Results showed that a dry powder inhaler loaded with umeclidinium and vilanterol produced a 14% lower risk of moderate or ...
London Free Press

How inhalers affect climate and what London hospitals are doing

Hydrofluoroalkanes are considered 1,400 to 3,700 times more potent than carbon dioxide – the primary driver of human-related ...
News-Medical.Net on MSN

Sustainable inhalers offer better outcomes for COPD patients

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

MannKind stock tumbles 37% on United Therapeutics inhaler news

Investing.com -- MannKind Corporation (NASDAQ:MNKD) shares fell 37% Wednesday after partner United Therapeutics unveiled a ...
Pulse Today

Resistant asthma in primary care: assessment, pitfalls and when to refer

Respiratory physicians Dr Hannah Petty and Dr Nita Sehgal discuss management of treatment resistant asthma in primary care ...
Healthline

What’s the Difference Between Short-Acting and Long-Acting Bronchodilators? Answered by an Expert

Short-acting bronchodilators offer quick relief of respiratory symptoms, with effects lasting from 30 minutes to several hours. They are often used as a rescue medication. Long-acting bronchodilators ...

MannKind Corporation (MNKD) Q4 2025 Earnings Call Transcript

Q4 2025 Earnings Call February 26, 2026 9:00 AM ESTCompany ParticipantsMichael Castagna - CEO & DirectorChristopher ...

Pharmaceutical Drug Delivery Markets and Competition Forecast 2026-2032 with Global, Regional and Country-Level Analysis

The "Pharmaceutical Drug Delivery Market - Global Forecast 2026-2032" report has been added to ResearchAndMarkets.com's ...